Tag: Cancer: Prostate
Neoadjuvant Chemohormonal Therapy Aids Locally Advanced Prostate Cancer
Significant benefits in terms of three-year biochemical progression-free survival seen for NCHT versus neoadjuvant hormonal therapy
New Prostate Cancer Urine Test Has High Diagnostic Accuracy
Higher AUROC seen for 18-gene MPS2 model compared with current guideline-endorsed biomarkers
HYPORT Noninferior for GU, GI Toxicity in Prostate Cancer
24-month differences in genitourinary and gastrointestinal change scores were noninferior for HYPORT versus COPORT
Single Invitation for PSA Screening Cuts Prostate Cancer Deaths
Small, but significant reduction seen in prostate cancer deaths, but no reduction seen in all-cause mortality
Number of Prostate Cancer Cases Set to Increase to 2.9 Million in 2040
Large increases in prostate cancer expected due to changing age structure and improving life expectancy
MRI + Blood Test Results May Cut Unnecessary Biopsies for Prostate Cancer
Patient-tailored biopsy decisions still maintain high sensitivity
New Federal Rule Means Hospitals Need Written Consent for Pelvic, Prostate Exams
Relugolix Beneficial for Prostate Cancer Patients Undergoing Radiotherapy
Short- or longer-term relugolix achieves sustained castration in patients with localized and advanced prostate cancer
Disparities in Transgender Prostate Screening Uptake Driven by Clinicians
Clinician-led recommendations for and discussions of PSA screening explained differences between cisgender and transgender screening rates
Plant-Based Food Intake Linked to Better QoL in Prostate Cancer
Higher plant-based diet index linked to better scores for sexual function, urinary irritation/obstruction, urinary incontinence, hormonal/vitality
